canopy-a: canakinumab for early stage nsclc
Published 4 years ago • 261 plays • Length 3:37Download video MP4
Download video MP3
Similar videos
-
1:30
canopy-a: canakinumab for resected nsclc
-
5:13
clinical trial for early-stage non-small cell lung cancer following surgery
-
4:43
treating for stage iii nsclc after progression on durvalumab
-
6:06
stage iii nsclc: when to start durvalumab
-
1:54
highlights in lung cancer at esmo 2022
-
6:23
adaura trial; early stage non–small cell lung cancer
-
1:36
fda approval of durvalumab for stage iii unresectable nsclc
-
1:14
destiny-lung01: a practice-changing trial for nsclc
-
1:38
practical considerations for durvalumab in stage 3 nsclc
-
1:26
unmet needs in limited-stage small cell lung carcinoma
-
3:39
what is durvalumab’s future as a treatment option in lung cancer?
-
0:49
the importance of metex14 testing in nsclc
-
3:53
molecular testing in early stage non-small cell lung cancer
-
0:46
fda approves capmatinib for advanced lung cancer
-
1:27
molecular testing in early stage non-small cell lung cancer
-
2:01
new lung cancer screening robot enable early detection, better outcomes
-
3:59
pacific trial of durvalumab for stage iii nsclc
-
4:25
durvalumab tolerability in non–small cell lung cancer
-
1:04
ascend-2 and ascend-3 trials: ceritinib in alk-rearranged nsclc with brain metastases